CFA
KLRS

Carroll Financial Associates’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Carroll Financial Associates’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		$13K Buy
+43
New +$13K ﹤0.01% 1102